This is an antibody developed by antibody phage display technology using a human naive antibody gene library and human serum amyloid A1 antigen. For this antibody both the heavy and light chains are cloned and expressed, generating full-length antibodies.
Produktmerkmale
This antibody can be detected with anti-mouse Fc secondary antibodies.
Aufreinigung
Protein A purification
Immunogen
No immunization, animal-free antibody development. Antigen: human serum amyloid A1
SAA1
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
ELISA: 1-12 μg/mL as coating antibody 0.5-5 μg/mL as detection antibody Optimal working dilution should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
PBS, pH 7.4,
Lagerung
-20 °C
Target
SAA1
(Serum Amyloid A1 (SAA1))
Andere Bezeichnung
Serum Amyloid A1
Hintergrund
Serum Amyloid A1 (SAA1) is a prominent acute-phase protein in humans, primarily produced by the liver in response to inflammation. It plays a role in the immune system, potentially aiding in tissue repair, acting as an antibacterial agent, and signaling the migration of immune cells to sites of infection. Levels of SAA1 can increase dramatically (up to 1000-fold) during inflammatory states triggered by infections, injury, or chronic diseases.